Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Virol Methods ; 223: 19-24, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26205552

RESUMEN

Eastern Equine Encephalitis virus (EEEV) is a medically important pathogen that can cause severe encephalitis in humans, with mortality rates ranging from 30 to 80%. Unfortunately there are no antivirals or licensed vaccines available for human use, and laboratory diagnosis is essential to differentiate EEEV infection from other pathogens with similar clinical manifestations. The Arboviral Diseases Branch (ADB) reference laboratory at the CDC Division of Vector-Borne Diseases (DVBD) produces reference antigens used in serological assays such as the EEEV immunoglobulin M antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA). However, EEEV is classified as a HHS select agent and requires biosafety level (BSL) three containment, limiting EEEV antigen production in non-select agent and BSL-2 laboratories. A recombinant Sindbis virus (SINV)/EEEV has been constructed for use under BSL-2 conditions and is not regulated as a select agent. Cell culture production of inactivated EEEV antigen from SINV/EEEV for use in the EEEV MAC-ELISA is reported here. Cell culture conditions and inactivation procedures were analyzed for SINV/EEEV using a recently developed antigen production algorithm, with the MAC-ELISA as the performance indicator.


Asunto(s)
Antígenos Virales/genética , Antígenos Virales/aislamiento & purificación , Virus de la Encefalitis Equina del Este/genética , Encefalomielitis Equina/diagnóstico , Virus Sindbis/genética , Animales , Anticuerpos Antivirales/sangre , Antígenos Virales/inmunología , Ensayo de Inmunoadsorción Enzimática/métodos , Caballos , Humanos , Inmunoglobulina M/sangre , Virus Sindbis/crecimiento & desarrollo , Cultivo de Virus/métodos
2.
J Virol Methods ; 208: 66-78, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25102428

RESUMEN

Arboviruses are medically important pathogens that cause human disease ranging from a mild fever to encephalitis. Laboratory diagnosis is essential to differentiate arbovirus infections from other pathogens with similar clinical manifestations. The Arboviral Diseases Branch (ADB) reference laboratory at the CDC Division of Vector-Borne Diseases (DVBD) produces reference antigens used in serological assays such as the virus-specific immunoglobulin M antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA). Antigen production in cell culture has largely replaced the use of suckling mice; however, the methods are not directly transferable. The development of a cell culture antigen production algorithm for nine arboviruses from the three main arbovirus families, Flaviviridae, Togaviridae, and Bunyaviridae, is described here. Virus cell culture growth and harvest conditions were optimized, inactivation methods were evaluated, and concentration procedures were compared for each virus. Antigen performance was evaluated by the MAC-ELISA at each step of the procedure. The antigen production algorithm is a framework for standardization of methodology and quality control; however, a single antigen production protocol was not applicable to all arboviruses and needed to be optimized for each virus.


Asunto(s)
Antígenos Virales/aislamiento & purificación , Bunyaviridae/crecimiento & desarrollo , Flaviviridae/crecimiento & desarrollo , Estándares de Referencia , Togaviridae/crecimiento & desarrollo , Inactivación de Virus , Algoritmos , Animales , Bunyaviridae/química , Bunyaviridae/fisiología , Técnicas de Cultivo de Célula , Ensayo de Inmunoadsorción Enzimática/métodos , Flaviviridae/química , Flaviviridae/fisiología , Humanos , Togaviridae/química , Togaviridae/fisiología , Cultivo de Virus/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA